(Q72602270)
Statements
Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age (English)
D. F. Clarke
D. George
R. L. Milsap
E. Pogonowska-Wala
J. Owerbach
E. Lebenthal